E-mail:
fongp@mskcc.org Peter Fong joined the Office of Technology Development in 2009, where he is a licensing manager and assists in the formation of new ventures. Additionally, he helps to administer Memorial Sloan-Kettering Cancer Center’s Technology Development Fund (TDF).
Peter received a PhD degree in biomedical engineering in 2003 from Yale University. His distinctions while at Yale include a Brown-Coxe Postdoctoral Fellowship.
Prior to joining the Office of Technology Development, Peter had a leadership role at Carigent Therapeutics from 2005 through 2008. There, he served as co-founder and interim CEO during the company’s initial launch and prefinancing stage, and as head scientist and director after the company completed its $2-million series A financing. He also was integral in the formation of GoCrossCampus, a Yale University startup, helping the company close a series A financing in 2007.
From 2005 through 2007, Peter also served as an expert consultant to a US law firm involved with intellectual property litigation related to advanced drug delivery devices. Previously, he worked as a Six-Sigma certified product developer at General Electric, where he managed a portfolio of three global GE polymer products.
